41 studies found for:    SDF-1
Show Display Options
Rank Status Study
1 Unknown  The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
Conditions: Laryngeal Cancer;   Hypopharyngeal Cancer;   Metastasis
Intervention:
2 Unknown  Functional Improvement of Progenitor Cells and Endothelial Function by Vildagliptin in Diabetes Mellitus (FINNjA-DM).
Condition: SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors
Intervention: Drug: Vildagliptin
3 Unknown  The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma
Condition: Oral Cancer
Intervention:
4 Active, not recruiting NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: NOX-A12
5 Recruiting Diabetic Macular Edema Treated With Ozurdex (DMEO)
Condition: Diabetic Macular Edema
Intervention: Drug: OZURDEX
6 Active, not recruiting Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: G-CSF;   Drug: Plerixafor;   Drug: Mitoxantrone;   Drug: Etoposide;   Drug: Cytarabine
7 Completed Effect of Sitagliptin on Endothelial Progenitor Cells
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Sitagliptin
8 Completed AMD3100 to Mobilize Stem Cells for Donation
Conditions: Healthy;   Blood Component Removal
Intervention: Drug: AMD3100
9 Completed
Has Results
Study on the Efficacy and Mechanism of Cardiac Rehabilitation for Stem Cell Mobilization and Heart Failure Improvement
Condition: Myocardial Infarction
Intervention: Behavioral: cardiac rehabilitation
10 Completed
Has Results
Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV
Conditions: Diabetes;   Insulin Resistance
Interventions: Drug: Sitagliptin;   Drug: Placebo
11 Recruiting Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation
Conditions: Chronic Lymphocytic Leukemia;   Lymphoma;   Multiple Myeloma
Intervention: Drug: Plerixafor
12 Completed Study to Evaluate the Safety of a Single Escalating Dose of ACRX-100 in Adults With Ischemic Heart Failure
Condition: Heart Failure
Intervention: Biological: ACRX-100
13 Completed NOX-A12 First-in-human (FIH) Study
Condition: Autologous Stem Cell Transplantation
Intervention: Drug: NOX-A12
14 Active, not recruiting NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: NOX-A12
15 Active, not recruiting
Has Results
Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: Erlotinib hydrochloride
16 Recruiting Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Condition: T-Lymphocytopenia, Idiopathic CD4-Positive
Intervention:
17 Not yet recruiting Correlation of CXCR4 Expression in Premature Infants With a Diagnosis of Autism at 24 Months
Conditions: Autism Spectrum Disorder;   Prematurity
Intervention:
18 Unknown  Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)
Condition: Acute Myeloid Leukemia
Interventions: Drug: plerixafor;   Drug: decitabine
19 Unknown  The Role of Fibrocytes in Acute Lung Injury
Condition: Acute Lung Injury(ALI)
Intervention:
20 Completed An Evaluation of Safety and Efficacy of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers
Condition: Stem Cell Mobilization
Intervention: Drug: AMD3100

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years